Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Fangzhou Inc. Strengthens Partnerships with Tencent and Baidu, Unveiling its "AI Agent Solution" 2024-12-02 15:21
MGI Tech announces partnership with Universidad de San Martín de Porres to strengthen human genetics research 2024-12-02 11:16
Everest Medicines Announces Acceptance of VELSIPITY® New Drug Application in Hong Kong 2024-12-02 07:40
When ancient cures meet smart tech: Level up your health 2024-12-01 19:34
CBC Group Completes Strategic Acquisition of UCB's Mature Product Portfolio in China 2024-11-30 09:00
BGM Group Ltd Pioneers Innovation in AI Technology, Fostering Holistic Integration of Healthcare and Insurtech 2024-11-29 23:58
MicuRx: Successfully Completes Phase III Clinical Trial of MRX-4 for Injection in China 2024-11-29 22:00
Minghui Pharmaceutical Announces Positive Topline Results from Phase Ⅲ Trial of MH004 (Tofacitinib Etocomil) Ointment in Mild to Moderate Atopic Dermatitis 2024-11-29 20:31
"Are your Hands & Feet trying to tell you something?" - Ask leading Health Experts 2024-11-29 13:30
Akeso to Present at Citi 2024 Global Healthcare Conference and the 7th Annual Evercore HealthCONx Conference 2024-11-29 10:23
Borsch Med Partners with Unity Pharmacies to Help Elderly Access Zeria Chondroitin-based Joint Health Supplements in Support of Healthy Ageing in Singapore 2024-11-29 10:00
Microbio Appoints Paul Brennan as Chair of the Board 2024-11-29 06:30
Lanchi Ventures Leads $42M Series A Financing for Allink Biotherapeutics to Accelerate Global Development of Bispecific Antibody and ADC Pipeline 2024-11-28 21:30
Allink Biotherapeutics Raises $42M Series A Financing to Accelerate Global Development of Bispecific Antibody and ADC Pipeline 2024-11-28 21:06
First Patient Dosed in Phase III ZIRCON-CP Trial of TLX250-CDx for Kidney Cancer Imaging in Chinese Patients 2024-11-28 17:22
New Indication of Olverembatinib Included into China 2024 National Reimbursement Drug List 2024-11-28 16:59
Own Your Story with AwarerHOME™ 2024-11-28 16:34
Everest Medicines Announces NEFECON®, the World's First Approved Treatment for IgA Nephropathy, is Included in China's National Reimbursement Drug List 2024-11-28 13:43
Antengene Announces XPOVIO®'s New Indication Included in 2024 China National Reimbursement Drug List, Making the Drug More Accessible to DLBCL Patients in the Country 2024-11-28 13:04
Innovent Announces First-Time Inclusion of SINTBILO® and New Indication for Olverembatinib in China's National Reimbursement Drug List 2024-11-28 12:07
1 10 11 12 13 14 976